Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public sector clients. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Metrics to compare | MCOVb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMCOVbPeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.3x | 18.8x | −0.4x | |
PEG Ratio | 0.10 | −0.28 | 0.00 | |
Price/Book | 5.3x | 1.7x | 2.6x | |
Price / LTM Sales | 1.2x | 0.9x | 3.2x | |
Upside (Analyst Target) | 26.3% | 21.5% | 45.4% | |
Fair Value Upside | Unlock | 20.7% | 7.0% | Unlock |